The Siteman Cancer Center has received renewal of its designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI).
The designation recognizes Siteman’s clinical research, basic science, community outreach and education activities. The renewal includes $23 million in research funding for the next five years.
“NCI designation as a Comprehensive Cancer Center confers the highest recognition of our exceptional cancer-focused scientists, clinicians and staff throughout Washington University and Barnes-Jewish Hospital,” says Timothy Eberlein, MD, Siteman director and chairman of surgery. “Most importantly, we are translating our innovative science into better treatments for the more than 40,000 cancer patients we see each year.”
Siteman is the only NCI-designated Comprehensive Cancer Center within a 240-mile radius of St. Louis. It offers the expertise of more than 350 Washington University research scientists and physicians, plus the staff and advanced technology of Barnes-Jewish Hospital. Siteman provides care for about 8,000 newly diagnosed cancer patients each year and offers access to more than 250 clinical trials.